96 results
Page 2 of 5
8-K
EX-1.1
d5dnzgnzn9n4hmlhh
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
ctow694k
19 Aug 22
Prospectus supplement for primary offering
8:42am
424B5
v4svmje41ehglduef1
19 Aug 22
Prospectus supplement for primary offering
8:37am
424B5
mh2tzdcqfjdvb0b891
16 Aug 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.2
5n4uofse4rkyo8c2qb8b
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
EX-99.1
zbav7qawwi7rco4jdula
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
EX-99.1
ftzd2pnx83b 50x17k
12 Aug 22
UNITY Biotechnology, Inc. Reports Second Quarter 2022
7:15am
424B5
1n4pb t4vy2sskbyecvv
13 May 22
Prospectus supplement for primary offering
4:18pm
8-K
EX-99.1
7alv0 fkco
10 May 22
UNITY Biotechnology, Inc. Reports First Quarter 2022
4:01pm
8-K
EX-99.1
yfs 53dtcnzq
15 Mar 22
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
8:05am
8-K
EX-99.1
0bm52b cz
3 Feb 22
UNITY Biotechnology Announces Restructuring to Advance Corporate Strategy and Focus on Key Ophthalmology Programs
4:06pm
8-K
EX-10.1
89b2jip2i1w ul7y1f7
20 Dec 21
Other Events
8:07am
8-K
EX-10.1
spbzxj4udwk4uuqlmbr
15 Dec 21
Entry into a Material Definitive Agreement
4:05pm